Delivery Order SPE2DB22D1106-SPE2DB25FFGF2
- Not listed
- The Defense Logistics Agency awarded a $5,239.50 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen's broader federal procurement relationships,...
- The Defense Logistics Agency awarded a $12,016.38 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed price contract, with performance in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,297.80 firm fixed price delivery order for Rabavert rabies vaccine with diluents, effective August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Rabavert rabies vaccine with diluents, valued at $18,968.07. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), represents a non-competitive set-aside procurement. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,047.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of September 12, 2025. This non-set-aside competitive award represents a single delivery order fulfillment under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for Rabavert rabies vaccine with diluents, valued at $1,467.06 with a firm fixed price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 23, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,239.50 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a completion date of June 30, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $40,441.62 for Rabavert rabies vaccine with diluents under a firm fixed-price contract. This non-set-aside award, issued on July 29, 2025, represents a child order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The vaccine will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a $2,816.02 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and carries no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,257.48 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of September 24, 2025. This non-set-aside, competitively awarded delivery order represents a firm fixed price transaction for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFGF2Delivery Order
The Defense Logistics Agency awarded a $41,916 firm fixed price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents on September 2, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside contract represents a competitively awarded delivery order executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company's performance under this delivery order supports DLA's medical supply chain operations and aligns with broader Defense Health Agency and military healthcare requirements. As a prime contractor under DLA's pharmaceutical procurement framework, AmerisourceBergen demonstrates significant capability in fulfilling federal medical supply needs through its established infrastructure and comprehensive pharmaceutical portfolio across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $41.9k | 9/2/25 |